galantamine has been researched along with huperzine a in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 12 (54.55) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Brossi, A; Greig, NH; Holloway, HW; Whittaker, NF; Yu, QS; Zhu, X | 1 |
| Brossi, A; Greig, NH; Holloway, HW; Kulkarni, SS; Lahiri, DK; Luo, W; Parrish, DA; Shafferman, A; Tweedie, D; Yu, QS | 1 |
| Feng, J; Liu, JS; Tang, XC; Xu, H; Zhou, TX | 1 |
| Houghton, PJ; Howes, MJ; Perry, NS | 1 |
| Badia, A; Camps, P; Clos, MV; Muñoz-Torrero, D; Roman, S | 1 |
| Beck, C; Blank, K; Colenda, CC; Doraiswamy, MP; Kalunian, DA; Lyketsos, CG; Yaffe, K | 1 |
| Adler, M; Albuquerque, EX; Aracava, Y; Fawcett, WP; Hamilton, TA; Kan, RK; Oliveira, M; Pereira, EF; Randall, WR; Romano, JA | 1 |
| Sivaprakasam, K | 1 |
| Beier, MT | 1 |
| Al-Abed, Y; Chavan, S; Ochani, K; Ochani, M; Parrish, WR; Pavlov, VA; Puerta, M; Rosas-Ballina, M; Tracey, KJ | 1 |
| An, JJ; Cheng, JF; Jiang, Y; Li, HJ; Li, P; Zhou, JL | 1 |
| Tang, XC; Wang, J; Zhang, HY | 1 |
| Adler, M; Akkerman, M; Albuquerque, EX; Aracava, Y; Pereira, EF | 1 |
| Hannongbua, S; Kitisripanya, N; Saparpakorn, P; Wolschann, P | 1 |
| Gurkas, E; Orhan, G; Orhan, IE | 1 |
| Aisen, PS; Cummings, J; Schneider, LS | 1 |
| Cesario, A; Del Bufalo, A; Fini, M; Frustaci, A; Russo, P | 1 |
| Aaron, CL; Gordon, RK; Moon, JE; Morasch, KC | 1 |
| Lee, KW; Park, C; Rampogu, S; Son, M; Zeb, A | 1 |
| Grigorev, VY; Grigoreva, LD; Rasdolsky, AN; Tinkov, OV | 1 |
| Andrisano, V; Cahlikova, L; Hostalkova, A; Hulcova, D; Jun, D; Korabecny, J; Kucera, T; Kunes, J; Marikova, J; Novakova, L; Opletal, L; Perez, DI; Siatka, T | 1 |
| Curtis, MA; Lin, SX; Sperry, J | 1 |
8 review(s) available for galantamine and huperzine a
| Article | Year |
|---|---|
Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders.
Topics: Alkaloids; Alzheimer Disease; Estrogens, Non-Steroidal; Galantamine; Humans; Isoflavones; Physostigmine; Phytoestrogens; Phytotherapy; Plant Extracts; Plant Preparations; Plants, Medicinal; Sesquiterpenes | 2003 |
Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation.
Topics: Alkaloids; Alzheimer Disease; Amyloid; Cholinergic Fibers; Cholinesterase Inhibitors; Galantamine; Inflammation; Neurofibrillary Tangles; Plaque, Amyloid; Receptors, Nicotinic; Sesquiterpenes | 2006 |
Harmless herbs? Think again: merits of a complete medication history.
Topics: Aged; Alkaloids; Cholinesterase Inhibitors; Dementia; Evidence-Based Medicine; Galantamine; Geriatric Assessment; Geriatrics; Ginkgo biloba; Herb-Drug Interactions; Humans; Medical History Taking; Neuroprotective Agents; Nootropic Agents; Phytotherapy; Sesquiterpenes | 2006 |
Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.
Topics: Acetylcholine; Alkaloids; Animals; Anti-Inflammatory Agents; Cholinergic Agents; Cholinesterase Inhibitors; Dementia, Vascular; Disease Models, Animal; Donepezil; Galantamine; Humans; Indans; Inflammation; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, Cholinergic; Rivastigmine; Sesquiterpenes; Signal Transduction | 2009 |
An overview on natural cholinesterase inhibitors--a multi-targeted drug class--and their mass production.
Topics: Alkaloids; Alzheimer Disease; Cholinesterase Inhibitors; Galantamine; Humans; Huperzia; Liliaceae; Sesquiterpenes | 2011 |
Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.
Topics: Alkaloids; Alzheimer Disease; Amino Acids; Animals; Cholinesterase Inhibitors; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Donepezil; Drug Approval; Galantamine; Ginkgo biloba; Half-Life; History, 20th Century; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Psychotropic Drugs; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Sesquiterpenes; Vitamin B Complex; Vitamin E | 2012 |
Multitarget drugs of plants origin acting on Alzheimer's disease.
Topics: Alkaloids; Alzheimer Disease; Animals; Biological Products; Cholinesterase Inhibitors; Crocus; Drug Discovery; Galantamine; Galanthus; Ginkgo biloba; Humans; Huperzia; Neuroprotective Agents; Physostigmine; Plant Extracts; Plants; Salvia; Sesquiterpenes | 2013 |
Pyridine alkaloids with activity in the central nervous system.
Topics: Alkaloids; Amphibians; Animals; Bacteria; Central Nervous System Diseases; Fungi; Nicotine; Plants; Pyridines; Receptors, Nicotinic | 2020 |
14 other study(ies) available for galantamine and huperzine a
| Article | Year |
|---|---|
Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines.
Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cyclic N-Oxides; Humans; Isomerism; Oxazines; Structure-Activity Relationship | 2002 |
Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine.
Topics: Acetophenones; Acetylcholinesterase; Animals; Benzofurans; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Crystallography, X-Ray; Furans; Heterocyclic Compounds, 3-Ring; Humans; Models, Molecular; Oxepins; Stereoisomerism; Structure-Activity Relationship; Torpedo | 2006 |
Effect of cholinesterase inhibition in vitro by huperzine analogs.
Topics: Acetylcholinesterase; Alkaloids; Animals; Cholinesterase Inhibitors; Erythrocyte Membrane; Galantamine; Physostigmine; Rats; Sesquiterpenes; Structure-Activity Relationship | 1994 |
Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors.
Topics: Acetylcholine; Alkaloids; Aminoquinolines; Animals; Atropine; Cholinesterase Inhibitors; Dopamine Antagonists; Dose-Response Relationship, Drug; Galantamine; Haloperidol; Heterocyclic Compounds, 4 or More Rings; In Vitro Techniques; Mecamylamine; Nicotinic Agonists; Nicotinic Antagonists; Parasympatholytics; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Sesquiterpenes | 2005 |
Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease.
Topics: Aged; Alkaloids; Alzheimer Disease; Brain; Caregivers; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Diagnostic and Statistical Manual of Mental Disorders; Galantamine; Geriatric Psychiatry; Health Services for the Aged; Humans; Phenylcarbamates; Professional-Family Relations; Rivastigmine; Sesquiterpenes; Tacrine; United States | 2006 |
Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents.
Topics: Acetylcholinesterase; Alkaloids; Animals; Atropine; Behavior, Animal; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Galantamine; Guinea Pigs; Insecticides; Lethal Dose 50; Neurons; Organophosphate Poisoning; Organophosphorus Compounds; Paraoxon; Poisoning; Pyridostigmine Bromide; Sarin; Sesquiterpenes; Soman; Time Factors | 2006 |
Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.
Topics: Acetylcholinesterase; Alkaloids; alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Atropine Derivatives; Brain; Cholinesterase Inhibitors; Cytokines; Endotoxemia; Enzyme-Linked Immunosorbent Assay; Female; Galantamine; Injections, Intraperitoneal; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Parasympatholytics; Receptors, Nicotinic; Sesquiterpenes; Tumor Necrosis Factor-alpha; Vagotomy | 2009 |
Two-dimensional turbulent flow chromatography coupled on-line to liquid chromatography-mass spectrometry for solution-based ligand screening against multiple proteins.
Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cholinesterases; Chromatography, Gel; Chromatography, Liquid; Equipment Design; Galantamine; Ligands; Mass Spectrometry; Peptide Library; Protein Binding; Proteins; Reproducibility of Results; Sensitivity and Specificity; Sesquiterpenes; Structure-Activity Relationship | 2009 |
Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine.
Topics: Acetylcholinesterase; Alkaloids; Animals; Antidotes; Chemical Warfare Agents; Donepezil; Dose-Response Relationship, Drug; Galantamine; Guinea Pigs; Indans; Lethal Dose 50; Male; Phenylcarbamates; Piperidines; Poisoning; Rivastigmine; Sesquiterpenes; Soman; Time Factors; Toxicity Tests, Acute | 2009 |
Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM method.
Topics: Acetylcholinesterase; Alkaloids; Binding Sites; Cholinesterase Inhibitors; Galantamine; Hydrogen Bonding; Protein Binding; Sesquiterpenes | 2011 |
Physiological and neurobehavioral effects of cholinesterase inhibition in healthy adults.
Topics: Acetylcholinesterase; Adolescent; Adult; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Female; Galantamine; Humans; Indans; Male; Memory; Piperidines; Reaction Time; Sesquiterpenes; Young Adult | 2015 |
Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Binding Sites; Cholinesterase Inhibitors; Databases, Chemical; Donepezil; Drug Discovery; Galantamine; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Quantitative Structure-Activity Relationship; Sesquiterpenes | 2019 |
Structural Fractal Analysis of the Active Site of Acetylcholinesterase in Complexes with Huperzine A, Galantamine, and Donepezil.
Topics: Acetylcholinesterase; Alkaloids; Catalytic Domain; Cholinesterase Inhibitors; Donepezil; Fractals; Galantamine; Sesquiterpenes | 2021 |
Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Berberis; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Isoquinolines; Magnetic Resonance Spectroscopy; Plant Exudates | 2019 |